Grifols reported EUR333.1M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Alaunos Therapeutics USD 585K 260K Sep/2025
aTyr Pharma USD 4.8M 130K Sep/2025
GlaxoSmithKline GBP 2.16B 19M Sep/2025
Grifols EUR 333.1M 157M Sep/2025